4basebio PLC · LSE:4BB

Aberdeen Group plc reported a 7.57% stake in 4basebio PLC (TR-1 holding notification)

Event Nov 10, 2026 · Filed Nov 12, 2026

Aberdeen Group plc reported a 7.57% stake in 4basebio PLC, 1,456,310 shares on Nov 10, 2026. Filed Nov 12, 2026 (TR-1 holding notification).

Stake
7.57%
Shares
1,456,310
What changed
Holding notified

The filing in full

TR-1: Standard form for notification of major holdings

1\. Issuer Details

ISIN

GB00BMCLYF79

Issuer Name

4BASEBIO PLC

UK or Non-UK Issuer

UK

2\. Reason for Notification

An acquisition or disposal of voting rights

3\. Details of person subject to the notification obligation

Name

Aberdeen Group plc

City of registered office (if applicable)

Edinburgh

Country of registered office (if applicable)

United Kingdom

4\. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

City of registered office (if applicable)

Country of registered office (if applicable)

5\. Date on which the threshold was crossed or reached

10-Nov-2026

6\. Date on which Issuer notified

11-Nov-2026

7\. Total positions of person(s) subject to the notification obligation

.% of voting rights attached to shares (total of 8.A)% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)Total of both in % (8.A + 8.B)Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached7.5712530.0000007.5712531,456,310
Position of previous notification (if applicable)

8\. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)Number of direct voting rights (DTR5.1)Number of indirect voting rights (DTR5.2.1)% of direct voting rights (DTR5.1)% of indirect voting rights (DTR5.2.1)
GB00BMCLYF791,456,3107.571253
Sub Total 8.A1,456,3107.571253

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrumentExpiration dateExercise/conversion periodNumber of voting rights that may be acquired if the instrument is exercised/converted% of voting rights
Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrumentExpiration dateExercise/conversion periodPhysical or cash settlementNumber of voting rights% of voting rights
Sub Total 8.B2

9\. Information in relation to the person subject to the notification obligation

2\. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling personName of controlled undertaking% of voting rights if it equals or is higher than the notifiable threshold% of voting rights through financial instruments if it equals or is higher than the notifiable thresholdTotal of both if it equals or is higher than the notifiable threshold
Aberdeen Group plc
Aberdeen Group plcabrdn Holdings Limited
Aberdeen Group plcabrdn Inc.7.5712530.0000007.571253

10\. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

If date does not apply, explain below

11\. Additional Information

In reference to Section 9, the shares detailed are managed by the named discretionary investment management entity within multiple portfolios on behalf of underlying clients, based on investment management agreements whereby the client has delegated the exercise of the voting power to the referenced investment manager.

This disclosure also reflects the fact that the voting rights effectively held indirectly by the underlying intermediate holding company abrdn Holdings Limited ("aHL") and held by the underlying investment management entity abrdn Inc. ("aInc") increased above the 5% notifiable threshold due to the participation in the Placing which completed on 10 November 2026. aHL now effectively holds and aInc holds the delegated voting rights to 7.571253% of the shares in 4basebio PLC.

12\. Date of Completion

11-Nov-2026

13\. Place Of Completion

Edinburgh, United Kingdom

  • * *
  • * *
HolderStakeShares
Aberdeen Group plc7.57%1,456,310

Source

Download original · View original at FCA

Related